Skip to content

R&D at other companies

TFX
TeleflexTFX
$44.39M+75.5%
ITG
Integer HoldingsITGR
$16.24M+14.4%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$22.61M+0.6%
Baxter International logo
Baxter InternationalBAX
$139M-0.7%
Medline, Inc.
 logo
Medline, Inc. MDLN
$20M+19.4%
Solventum logo
SolventumSOLV
$189M-2.1%

Other financials

Income statement

See full
Revenue$154.2M+4.1%
Gross profit$44.4M+5.2%
Operating income$23.4M+1.0%
Net income$17.5M+1.8%
EPS (diluted)$2.24+1.4%

Balance sheet

See full
Cash & equivalents$20.0M+42.4%
Total debt$156.1M-21.4%
Total equity$438.9M+21.7%
Total assets$674.7M+5.0%

Cash flow

See full
Operating cash flow$3.2M-76.8%
CapEx$2.9M+3.1%
Free cash flow$22.5M+151%

Valuation

See full
Market cap$1.88B-3.6%

Profitability

See full
Gross margin28.4%-0.6pp
Operating margin15.2%-0.9pp
Net margin11.3%-0.3pp
FCF margin12.3%+2.0pp

Returns & leverage

See full
Return on equity17.2%-2.2pp
Debt / equity0.4×-0.2×
Current ratio2.9×+0.3×

Where this comes from

Reported directly by UFP Technologies in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: UFP Technologies’s 10-K, filed February 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about UFP Technologies's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is UFP Technologies's R&D?
UFP Technologies (UFPT) reported R&D of $2.15M in Q4 2025.
How has UFP Technologies's R&D changed year-over-year?
UFP Technologies's R&D decreased by 17.3% year-over-year, from $2.6M to $2.15M.
What is the long-term trend for UFP Technologies's R&D?
Over 4 years (2021 to 2025), UFP Technologies's R&D has grown at a 0.3% compound annual growth rate (CAGR), from $8.5M to $8.6M.
What does R&D mean?
Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.